Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
|
Your cart is empty |
|||
Books > Law > Laws of other jurisdictions & general law > Social law > Public health & safety law
Various types of traditional medicine and other medical practices referred to as complementary or alternative medicine are increasingly used in both developing and developed countries. In order to promote safe and appropriate use of these medicines and practices, as well as to ensure the quality of service and practitioners, national regulations are vital. Establishing national policies on traditional medicine, and/or complementary/alternative medicine and their medical practices, should therefore include creation of legal frameworks. This review summarizes the legal status of several major practices in traditional medicine and complementary/alternative medicine in 123 countries. It includes data on: the use of traditional and complementary/alternative medicine; the regulatory situation of traditional and complementary/alternative remedies and practitioners; health insurance coverage of traditional and complementary/alternative medicine; education and training of practitioners of traditional and complementary/alternative medicine. Information provided in this review will be useful not only to policy makers, but also to researchers, universities, the public, insurance companies and pharmaceutical industries.
Sweeping changes are being proposed as Canadians examine our health care system. But what are the legal implications of health care reform? In this timely collection, lawyers and legal scholars discuss a variety of topics in health care reform, including regulation of private care, interpretation of the Canada Health Act, and the constitutional implications of proposed reforms. Barbara von Tigerstrom is currently studying at the University of Cambridge in England. Timothy Caulfield lives in Edmonton, where he teaches at the University of Alberta.
Students and professional nurses at any level of clinical practice will find this book to be a vital resource on the basic legal concepts and principles of malpractice, liability, and risk management, and their implications for the profession. The book also provides detailed strategies for dealing with these issues. The content is also highly relevant to practitioners in all other health care and legal disciplines that collaborate in the delivery of health care. Issues discussed include the expanding and evolving roles for professional nurses and the concomitant legal accountability and risk for liability, the increasing incidence of nurses named as defendants in malpractice lawsuits, anticipated changes in our health care delivery system, and breakthroughs in science and technology that will present new legal questions. The book also includes material on other important facets of today's nursing practice, including the growing phenomenon of tele-nursing, the essentials of malpractice insurance, and the legal significance of documentation and patients' medical records. It helps the reader identify the nurse at risk for a malpractice suit and the characteristics of the patient likely to sue. The appendices provide information on state laws concerned with access to medical records, a list of useful websites, a list of state boards of nursing, and a glossary of important terms.
Using MDS Quality Indicators to Improve Outcomes is designed to be use d by your staff immediately upon purchase. All MDS QIs are covered in the 11 Monitoring plans, with corresponding Data Retrieval Worksheets. The worksheets get your staff immediately collecting data on the area s that the MDS QIs indicate need for improvement. Monitoring plans exa mine care delivery in areas such as nutrition, skin care, and medicati on use. Plus you'll get expert guidance on developing an ongoing quali ty improvement process. This book supports a team process to successfu lly improve care delivery systems.
From the very beginning of the epidemic, AIDS was linked to punishment. Calls to punish people living with HIV-mostly stigmatized minorities-began before doctors had even settled on a name for the disease. Punitive attitudes toward AIDS prompted lawmakers around the country to introduce legislation aimed at criminalizing the behaviors of people living with HIV. Punishing Disease explains how this happened-and its consequences. With the door to criminalizing sickness now open, what other ailments will follow? As lawmakers move to tack on additional diseases such as hepatitis and meningitis to existing law, the question is more than academic.
This volume contains authoritative briefings from members of the drafting group and from leading representatives of various physician, patient and citizens' groups, as well as from the Council of Europe. Patients' rights are placed in the context and perspective of other significant emergent trends and issues: patient education and health education; provider-patient relationships; and social rights and citizen views on health-care reforms. The various strategic options for furthering the implementation of patients' rights are formulated, the emphasis being on options which could be selected and adapted to fit the respective contexts of different countries, underlining the different roles of different organizations, including international ones.
Evaluates the risks to human health and the environment posed by exposure to chloroform, a volatile liquid used in pesticide formulations and as a solvent and chemical intermediate. Its use as an anaesthetic and in proprietary medicines has been discontinued in many countries following well-documented reports of adverse effects on respiratory, cardiac and liver function. Exposure of the general public occurs via food, drinking-water, and indoor air, with water use in homes making a substantial contribution to levels in indoor air. Studies have demonstrated significant dermal absorption while showering. The most extensive chapter reviews the results of toxicity studies in laboratory animals and in vitro test systems. While both the liver and the kidneys are target organs, the most universally observed toxic effect is damage to the liver. Studies indicate that cytotoxicity followed by cell proliferation is the most important cause for the development of liver and kidney tumours following experimental exposure to chloroform. The severity of toxic effects was observed to vary according to species, vehicle, and route of administration. A chapter on health effects in humans notes disturbances in respiratory and cardiovascu-lar functions observed following short-term exposure. As in animals, liver and kidney damage was the most frequently reported adverse effect of long-term exposure. Data were judged inadequate to implicate chloroform exposure via drinking-water as a cause of human cancer. Concerning effects on the environment, the report concludes that the low levels of chloroform in surface water should not pose a hazard to aquatic organisms. .,." produced with the usual conciseness andreadability..." - International Journal of Environmental Studies
Principles of Medical Law is the leading practitioner text in its field. Now in its fourth edition, it provides a comprehensive and scholarly account of the common law and statutory provisions governing healthcare provision in England and Wales. It offers an authoritative and up-to-date account of medical law whilst also seeking to set the law in context and critique its application. The contributors include many of the leading academics and practitioners working in the area of medical law today, who together offer a balanced, reliable, and considered perspective. The clear layout, accessible writing style, extensive referencing, and detailed index make this an indispensable research tool for practitioners and academics alike.
Poverty whether as drain theory at the start of the twentieth century or through garibi hatao towards the end of those 100 yearswas the predominant economic, political, and social paradigm within which late colonial, nationalist and post-independence era science policy was constructed. Whether as critics of Indias poverty, or as architects of measures for its eradication, Indias commentators called on a broad framework of science both to diagnose and treat poverty. Yet, when we think of science in India today, this earlier priority of poverty eradication is now hard to find. Poverty eradication as a goal in itself seems to have fallen off Indias scientific agenda almost entirely. What accounts for this? This volume asks: Has the problem of poverty in India been solved? Or, has it become inconvenient alongside the rise of new narratives that frame India as a site of remarkable economic growth? Indeed, has there been a loss of faith in the ability of science to tackle poverty? Together, the essays in this volume explore the broader implications for the new role of science in India: as a driver of economic growth for India, rather than as a solution to the persistence of poverty.
Consultant and long-time Food and Drug Administration (FDA) food labeling expert James Summers answers the many questions surrounding FDA food labeling regulations and compliance in Food Labeling Compliance Review. This comprehensive manual and fully searchable, accompanying CD-ROM are designed to aid in understanding the requirements of the FDA. Food Labeling Compliance Review is a must-have for regulatory officials, industry personnel, and others responsible for assuring that the label and labeling of domestic and imported food products in interstate commerce comply with the requirements of the Federal Food, Drug and Cosmetic Act, as amended. The new fourth edition of Food Labeling Compliance Review fully covers recently enacted provisions requiring labeling for allergens, trans fats, and qualified health claims. Clearly illustrated with dozens of charts, sample label panels and "Nutrition Facts" boxes, Food Labeling Compliance Review is the practical, no-nonsense tool needed by both the experienced and inexperienced food label reviewer. * Current, complete, and accurate food labeling guidance concerning FDA regulations * Covers new requirements for labeling allergens, trans fats, and qualified health claims * Essential for all food manufacturers, packers, labelers, relabelers, and distributors * Fully illustrated with clear Q and A explanations * Fully-searchable CD-ROM enables quick look ups
Das Buch arbeitet die zentralen Kriterien des Krankheitsbegriffs im Recht heraus. Die Beantwortung vieler rechtlicher Fragen im Bereich arztlichen Handelns ist abhangig von der Abgrenzung zwischen Heilung, Pravention und Enhancement und damit von der Unterscheidung zwischen Krankheit und Gesundheit. In den einzelnen Rechtsgebieten haben sich bislang unterschiedliche Krankheitsbegriffe entwickelt. Das Buch fuhrt Experten aus verschiedenen Rechtsbereichen zusammen, die Relevanz und Funktion des jeweiligen Krankheitsbegriffs vorstellen und auf dieser Basis Unterschiede und Gemeinsamkeiten diskutieren. Beleuchtet werden die ethische, die oeffentlich-rechtliche, die strafrechtliche und die zivilrechtliche Perspektive.
The United States uses 42 billion gallons of water a dayatreated to meet Federal drinking water standardsato support a variety of needs. The Safe Drinking Water Act (SDWA) not only contains Federal authority for regulating contaminants in drinking water delivery systems, it also includes the Drinking Water State Revolving Fund (DWSRF) program. The DWSRF was created to provide financing for infrastructure improvements of drinking water systems. Chapter 1 looks at our Nation's drinking water infrastructure structure and examine questions as to what is necessary for the Federal Government to do in the way of planning, reinvestment, and technical support of these systems to meet future needs. Drinking Water System Improvement Act of 2017 amended the Safe Drinking Water Act to improve public water systems as discussed in chapter 2.
A concise history of how American law has shaped-and been shaped by-the experience of contagion, "taking us from the smallpox outbreaks of the colonies to COVID-19. . . . The conclusion [Witt] arrives at is devastating." (Jennifer Szalai, New York Times)"One wishes that, six months ago, every member of Congress and the Trump administration had been forced to read and reckon with the history Witt neatly summarizes. But now in the aftermath of a close, bitterly fought election, let's hope that this book will help America chart its way forward."-Jill Filipovic, Washington Post From yellow fever to smallpox to polio to AIDS to COVID-19, epidemics have prompted Americans to make choices and answer questions about their basic values and their laws. In five concise chapters, historian John Fabian Witt traces the legal history of epidemics, showing how infectious disease has both shaped, and been shaped by, the law. Arguing that throughout American history legal approaches to public health have been liberal for some communities and authoritarian for others, Witt shows us how history's answers to the major questions brought up by previous epidemics help shape our answers today: What is the relationship between individual liberty and the common good? What is the role of the federal government, and what is the role of the states? Will long-standing traditions of government and law give way to the social imperatives of an epidemic? Will we let the inequities of our mixed tradition continue?
Praxishandbuch und Kommentar zu den aktuellen MDK-Begutachtungsrichtlinien verstandlich und mit vielen Fallbeispielen. Pflegedienstleitungen, Pflegeberater und freie Sachverstandige finden in diesem Handbuch alles Wissenswerte, um MDK-Gutachten zu verstehen, zu beurteilen, Fehler zu erkennen und Widerspruche zu begrunden. Ein Nachschlagewerk, das auch fur gesetzliche Betreuer und Fachanwalte fur Sozialrecht nutzlich ist. Alltaglich werden in Deutschland mehrere hundert Antrage auf eine Pflegestufe oder Hoherstufung abgelehnt. Viele zu recht - sehr viele zu Unrecht. Pflegefachkrafte und Pflegeleitungen sind oft erste Ansprechpartner fur ratlose Betroffene und deren Familien. Um Betroffene kompetent zu beraten und gemeinsam zu entscheiden, ob ein Zweitgutachten oder ein Widerspruch erfolgversprechend sind, setzt voraus, dass die Begutachtungsrichtlinien bekannt sind. Dieser Praxiskommentar erlautert die aktuellen Begutachtungsrichtlinien des MDS Punkt fur Punkt und weist auf mogliche Fehlerquellen hin - im Ablauf, den Begutachtungskriterien und der Bewertung, der Dokumentation, den Formalien. Fallbeispiele verdeutlichen die Anwendung der Richtlinien einer Begutachtung im Pflegealltag. Je besser die Richtlinie verstanden und Gutachten interpretiert werden konnen, desto grosser ist die Chance eine erneute Prufung der Pflegestufe einzufordern und berechtigte Anspruche gegenuber der Pflegeversicherung geltend zu machen. "
Today, scientists are using CRISPR/Cas9 and other molecular editing tools to alter human gametes and embryos, a practice known as human germline modification. In the near future, these efforts may lead to the birth of children with better health, improved memories, and extended lifespans. However, critics claim that human germline modification exceeds divine and natural boundaries, transforms reproduction into manufacture, and yields apocalyptic outcomes such as the collapse of democracy. Enhanced Beings: Human Germline Modification and the Law analyzes and critiques these objections on both biological and political grounds. Professor Kerry Lynn Macintosh discusses the hidden psychology behind the objections, and describes the laws that affect this new technology. Provocative and timely, Enhanced Beings argues that bans on human germline modification pose a threat to scientists and science, parents, children, foreigners, and society.
In the late 1980s, the median time for FDA to approve a new drug application (NDA) was 29 months. Industry, consumer groups, and FDA agreed that the time from submission of a drug or biologics application to FDA's decision was unacceptably long. Patient advocates argued that a drug in review--and therefore not available for sale -- could be the difference between life and death. Manufacturers argued that prolonged review times affected their ability to recoup the costs of research and development. This book examines the FDA's review of drug applications, with a focus on the Prescription Drug User Fee Act (PDUFA) and issues for reauthorization in 2012.
According to state reporting to the Government Accountability Office (GAO), there were at least 8 million active permits to carry concealed handguns in the United States as of December 31, 2011. States and local authorities control the issuance of concealed carry permits. Applicants who wish to obtain such permits are required to meet certain state eligibility requirements, such as minimum age and the lack of a felony conviction. States also decide which other states' permits to honour. Typically, states enter into reciprocity agreements that establish which out-of-state permit holders can carry concealed firearms within each state. This book provides an overview of the extent to which states allow concealed carry permits, and how select states' eligibility requirements and recognition of other states' permits differ.
In economic sectors crucial to human welfare - agriculture, education, and medicine - a small number of firms control global markets, primarily by enforcing intellectual property (IP) rights incorporated into trade agreements made in the 1980s onward. Such rights include patents on seeds and medicines, copyrights for educational texts, and trademarks in consumer products. According to conventional wisdom, these agreements likewise ended hopes for a 'New International Economic Order,' under which wealth would be redistributed from rich countries to poor. Sam F. Halabi turns this conventional wisdom on its head by demonstrating that the New International Economic Order never faded, but rather was redirected by other treaties, formed outside the nominally economic sphere, that protected poor countries' interests in education, health, and nutrition and resulted in redistribution and regulation. This illuminating work should be read by anyone seeking a nuanced view of how IP is shaping the global knowledge economy.
Methamphetamine: A Love Story presents an insider's view of the world of methamphetamine based on the life stories of thirty-three adults formerly immersed in using, dealing, and manufacturing meth in rural Oklahoma. Using a respectful tone towards her subjects, Shukla illuminates their often decades-long love affair with the drug, the attractions of the lifestyle, the eventual unsustainability of it, and the challenges of exiting the life. These personal stories reveal how and why people with limited economic means and inadequate resources become entrapped in the drug epidemic, while challenging longstanding societal views about addiction, drugs, drug policy, and public health.
A growing body of EU law and regulation is preoccupied with the protection of EU citizens from health and environmental risks. Which chemicals are safe and should be allowed on the market? How should the EU respond to public health emergencies, such as Ebola and other infectious diseases? Regulatory responses to these questions confront deep uncertainty, limited knowledge and societal contestation. In a time where the use of scientific expertise in EU policy-making is particularly contested, this book offers a timely contribution to both the academic and policy debate on the role of specialised expertise in EU public decision-making on risk and technology as well as on its intertwinement with executive power. It draws on insights from law, governance, political sciences, and science and technology studies, bringing together leading scholars in this field. Contributions are drawn together by a shared theoretical perspective, namely by their use of co-production as an analytical lens to study the intricate interplay between techno-scientific expertise and EU executive power. By so doing, this collection produces highly original insights into the development of the EU administrative state, as well as into the role of regulatory science in its construction. This book will be useful to scholars, practitioners, and policy-makers working on risk regulation and the role of expertise in public decision-making.
Featuring case studies and discussion questions, this textbook with revisions addressing significant changes to US food law offers accessible coverage appropriate to a wide audience of students and professionals. * Overviews the federal statutes, regulations, and regulatory agencies concerned with food regulation and introduces students to the case law and statutory scheme of food regulation * Focuses updated content on the 2011 FDA Food Safety Modernization Act (FSMA), the biggest change to US food law since the 1930s * Contains over 20% new material, particularly a rewritten import law chapter and revisions related to food safety regulation, health claims, and food defense * Features case studies and discussion questions about application of law, policy questions, and emerging issues
Public Health Law and Ethics: A Reader, 3rd Edition probes the legal and ethical issues at the heart of public health through an incisive selection of judicial opinions, scholarly articles, and government reports. Crafted to be accessible to students while thorough enough for use by practitioners, policy makers, scholars, and teachers alike, the reader can be used as a stand-alone resource or alongside the internationally acclaimed Public Health Law: Power, Duty, Restraint, 3rd Edition. This updated edition reader includes new discussions of today's most pressing health threats, such as chronic diseases, emerging infectious diseases, antimicrobial resistance, biosecurity, opioid overdose, gun violence, and health disparities.
|
You may like...
Technology, Innovation and Healthcare…
Bernadette J. Richards, Mark Taylor, …
Hardcover
R2,278
Discovery Miles 22 780
Curriculum Development for Medical…
Patricia A. Thomas, David E. Kern, …
Paperback
R1,117
Discovery Miles 11 170
Ending Childhood Obesity - A Challenge…
Amandine Garde, Joshua Curtis, …
Hardcover
R3,786
Discovery Miles 37 860
Genomic Messages - How the Evolving…
George Annas, Sherman Elias
Paperback
|